125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region

Abstract

(125)I brachytherapy is a feasible and effective modality for the treatment of locally advanced unresectable or recurrent ACC.

CT-Guided 125 I Brachytherapy in the Treatment of Distant Metastases in the Oral Cavity and Maxillofacial Region

“…4.) Discussion Although 125 I brachytherapy has been successfully applied in many solid tumors, our study is the first to use this modality in the treatment of oral and maxillofacial metastases [19]. It is significant because patients with oral and maxillofacial metastases can often feel the presence of these lesions and have obvious clinical symptoms in these regions [20,21].…”

Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx

“…Tselis et al [10] have reported on the successful treatment of 2 patients with esthesioneuroblastoma by means of brachytherapy, as a method of improving outcome in the curative and palliative approach of this disease. Huang et al [19] have concluded that brachytherapy is a feasible and effective modality for patients with locally advanced unresectable or recurrent sinonasal adenoid cystic carcinoma. Scepanovic et al [20] reported on a case of malignant melanoma of the nasal cavity and the nasopharynx that was treated postoperatively by means of brachytherapy.…”

The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy

“…In the treatment of head and neck cancers, particularly in parotid gland malignancies, [ 125 I] seed brachytherapy has earned a place as a viable treatment option, especially considering the decreased adverse side effects compared to EBRT [8][9][10][11]. Therefore, we focused our attention on radiation-induced skin side effects, which can significantly alter patient appearance.…”

“…One of the methods of radiotherapy, [ 125 I] seed brachytherapy, has the advantage of having a high local control rate when treating head and neck cancers, especially in the treatment of parotid gland cancers [6][7][8][9][10][11]. In addition to the high local control rate, the lack of severe side effects is also beneficial, as this can improve the patient's quality of life during cancer treatment [8][9][10][11].…”

“…In addition to the high local control rate, the lack of severe side effects is also beneficial, as this can improve the patient's quality of life during cancer treatment [8][9][10][11].…”